Drug intelligence / Profile preview

sulphur hexafluoride + gadopentetate dimeglumine

Development stage
Unknown
Lead developer
Bayer
Modality
Small Molecules
Administration
Intravenous
01

Overview

sulphur hexafluoride + gadopentetate dimeglumine is a diagnostic combination of two distinct contrast agents used in multimodal medical imaging, particularly for the characterization of focal liver lesions. Sulfur hexafluoride is a microbubble contrast agent composed of a sulfur hexafluoride gas core encapsulated in a phospholipid shell; it is administered intravenously to enhance acoustic backscatter in contrast-enhanced ultrasound (CEUS), providing real-time hemodynamic information. Gadopentetate dimeglumine is a paramagnetic gadolinium-based contrast agent (GBCA) that shortens the T1 and T2 relaxation times of water protons, thereby enhancing signal intensity in magnetic resonance imaging (MRI). The combined or sequential use of these agents allows for a comprehensive diagnostic assessment, integrating the real-time vascularity data from CEUS with the high-resolution tissue characterization and extracellular space evaluation provided by MRI, which is particularly valuable in differentiating hepatocellular carcinoma (HCC) from benign lesions like focal nodular hyperplasia (FNH).

Brand names
SonoVueLumasonMagnevist
Other names
sulphur hexafluoride + gadopentate dimeglumineSF6 + Gd-DTPAsulfur hexafluoride + gadopentetate dimeglumine

Beyond the preview

Go deeper on sulphur hexafluoride + gadopentetate dimeglumine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on sulphur hexafluoride + gadopentetate dimeglumine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call